GLOBAL MEDICAL REIT INC (GMRE)
US37954A2042 - REIT
Overall GMRE gets a fundamental rating of 4 out of 10. We evaluated GMRE against 126 industry peers in the Diversified REITs industry. While GMRE is still in line with the averages on profitability rating, there are concerns on its financial health. GMRE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
GMRE had positive earnings in the past year.
In the past year GMRE had a positive cash flow from operations.
GMRE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years GMRE had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 1.17%, GMRE perfoms like the industry average, outperforming 59.35% of the companies in the same industry.
GMRE's Return On Equity of 2.53% is in line compared to the rest of the industry. GMRE outperforms 56.10% of its industry peers.
GMRE has a Return On Invested Capital (2.44%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for GMRE is in line with the industry average of 2.95%.
The last Return On Invested Capital (2.44%) for GMRE is above the 3 year average (2.37%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.17% | ||
| ROE | 2.53% | ||
| ROIC | 2.44% |
ROA(3y)1.02%
ROA(5y)0.55%
ROE(3y)2.18%
ROE(5y)1.12%
ROIC(3y)2.37%
ROIC(5y)2.17%
1.3 Margins
GMRE's Profit Margin of 10.49% is fine compared to the rest of the industry. GMRE outperforms 61.79% of its industry peers.
In the last couple of years the Profit Margin of GMRE has declined.
With a decent Operating Margin value of 26.92%, GMRE is doing good in the industry, outperforming 61.79% of the companies in the same industry.
In the last couple of years the Operating Margin of GMRE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.92% | ||
| PM (TTM) | 10.49% | ||
| GM | N/A |
OM growth 3Y14.97%
OM growth 5Y-8.47%
PM growth 3YN/A
PM growth 5Y-6.24%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
GMRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GMRE has about the same amount of shares outstanding.
The number of shares outstanding for GMRE has been increased compared to 5 years ago.
GMRE has a better debt/assets ratio than last year.
2.2 Solvency
GMRE has an Altman-Z score of 0.38. This is a bad value and indicates that GMRE is not financially healthy and even has some risk of bankruptcy.
GMRE's Altman-Z score of 0.38 is on the low side compared to the rest of the industry. GMRE is outperformed by 62.60% of its industry peers.
GMRE has a debt to FCF ratio of 10.47. This is a negative value and a sign of low solvency as GMRE would need 10.47 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.47, GMRE belongs to the top of the industry, outperforming 84.55% of the companies in the same industry.
A Debt/Equity ratio of 1.05 is on the high side and indicates that GMRE has dependencies on debt financing.
GMRE's Debt to Equity ratio of 1.05 is in line compared to the rest of the industry. GMRE outperforms 56.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 10.47 | ||
| Altman-Z | 0.38 |
ROIC/WACC0.34
WACC7.19%
2.3 Liquidity
GMRE has a Current Ratio of 0.20. This is a bad value and indicates that GMRE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.20, GMRE is doing worse than 96.75% of the companies in the same industry.
A Quick Ratio of 0.20 indicates that GMRE may have some problems paying its short term obligations.
GMRE's Quick ratio of 0.20 is on the low side compared to the rest of the industry. GMRE is outperformed by 96.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.2 | ||
| Quick Ratio | 0.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.00% over the past year.
Measured over the past years, GMRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 231262.79% on average per year.
GMRE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.73%.
Measured over the past years, GMRE shows a very strong growth in Revenue. The Revenue has been growing by 21.53% on average per year.
EPS 1Y (TTM)15%
EPS 3Y36.72%
EPS 5Y231262.79%
EPS growth Q2Q-200%
Revenue 1Y (TTM)2.73%
Revenue growth 3Y14.61%
Revenue growth 5Y21.53%
Revenue growth Q2Q-9.22%
3.2 Future
Based on estimates for the next years, GMRE will show a very negative growth in Earnings Per Share. The EPS will decrease by -43.81% on average per year.
GMRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.62% yearly.
EPS Next Y-94.09%
EPS Next 2Y-63.52%
EPS Next 3Y-43.81%
EPS Next 5YN/A
Revenue Next Year-5.25%
Revenue Next 2Y-0.55%
Revenue Next 3Y0.62%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 35.26 indicates a quite expensive valuation of GMRE.
GMRE's Price/Earnings ratio is in line with the industry average.
GMRE is valuated rather expensively when we compare the Price/Earnings ratio to 24.92, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 596.47, GMRE can be considered very expensive at the moment.
GMRE's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, GMRE is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.26 | ||
| Fwd PE | 596.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GMRE is valued a bit cheaper than the industry average as 73.17% of the companies are valued more expensively.
GMRE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GMRE is cheaper than 91.87% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.11 | ||
| EV/EBITDA | 11.89 |
4.3 Compensation for Growth
A cheap valuation may be justified as GMRE's earnings are expected to decrease with -43.81% in the coming years.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y-63.52%
EPS Next 3Y-43.81%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.38%, GMRE is a good candidate for dividend investing.
The stock price of GMRE dropped by -20.88% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 6.06, GMRE pays a better dividend. On top of this GMRE pays more dividend than 92.68% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, GMRE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.38% |
5.2 History
The dividend of GMRE decreases each year by -1.06%.
GMRE has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of GMRE decreased recently.
Dividend Growth(5Y)-1.06%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
438.45% of the earnings are spent on dividend by GMRE. This is not a sustainable payout ratio.
The Dividend Rate of GMRE has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP438.45%
EPS Next 2Y-63.52%
EPS Next 3Y-43.81%
GLOBAL MEDICAL REIT INC
NYSE:GMRE (4/26/2024, 7:04:00 PM)
After market: 8.11 0 (0%)8.11
+0.02 (+0.25%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap531.93M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.38% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.26 | ||
| Fwd PE | 596.47 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.17% | ||
| ROE | 2.53% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 26.92% | ||
| PM (TTM) | 10.49% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.2 | ||
| Quick Ratio | 0.2 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)15%
EPS 3Y36.72%
EPS 5Y
EPS growth Q2Q
EPS Next Y-94.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.73%
Revenue growth 3Y14.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y